Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test

Part of paid clinical trials in Iowa City, Iowa.

Sponsor
Andrew Pouw, MD
Study ID
NCT05690152
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • EyeSimplify web-browser-based visual field test — DEVICE
    All patients will be in a single arm: patients will have one or both eyes (dependent on inclusion/exclusion criteria) tested with the EyeSimplify visual field test biweekly for 6 months.

Study Details

The goal of this clinical trial is to assess patient persistence and adherence with a 6-month period of at-home visual field testing, using a novel web-based visual field test (EyeSimplify, M\&S Technologies, Niles, IL). The main questions this clinical trials aims to answer are: 1. How adherent patients are to biweekly testing at home for 6 months, and 2. How patients feel the ease of user experience of the test was, and 3. Whether the EyeSimplify platform is able to detect any worsening of glaucoma-related visual field performance that can be corroborated by standard of care, office-based testing. Participants will be given iPads with links to the EyeSimplify visual field test, and asked to take the EyeSimplify tests at home biweekly for six months. The test takes between 10 to 15 minutes to do and participants will have no additional responsibilities between tests. Researchers will send reminders for patients to complete the at-home tests at periodic intervals, and if worsening on the at-home test platform is suggested by test results, researchers will arrange for return visits to the office to compare the EyeSimplify test results to standard-of-care, office-based testing. At the conclusion of the study, participant adherence to the 6-month biweekly testing schedule will be assessed and participants will be surveyed for their perceptions regarding the EyeSimplify platform's ease of usability and user experience.

Key Dates

Start date
Feb 6, 2024
Status verified
Apr 2026
Primary completion
Mar 10, 2025
Completion
Mar 10, 2025

Study Design

Enrollment
8 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Single Arm
    All patients will be in a single arm: patients will have one or both eyes (dependent on inclusion/exclusion criteria) tested with the EyeSimplify visual field test biweekly for 6 months.

Primary Outcome Measure

EyeSimplify Self-Test Adherence [ Time Frame: Subjects will be asked to self-test once every two weeks for six months. ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of IowaIowa CityIowa52242-

Find similar trials in Iowa City, IA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
University of Iowa· Iowa City, IA

Related Studies